CP60.F The Cooper Companies, Inc.

Healthcare Medical Instruments & Supplies Frankfurt Exchange
57.17 EUR
Close of Nov 12, 2026
46.01 74.50
Market cap
EUR 10.9B
P/E
22.9x
P/B
1.45x
ROE
7.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is CP60.F undervalued?

Graham number
Price57.17
Graham value47.12
Premium21.3%

CP60.F trades 21.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The Cooper Companies, Inc. fundamental analysis

No fundamental analysis for The Cooper Companies, Inc. yet.

The Cooper Companies, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices…

Full company profile